Delivery Order SPE2DB20D9759-SPE2DB23FD5QD

Award Date 9/25/23
Potential Completion Date 10/17/23
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency Troop Support Medical awarded a $5,599.44 delivery order to DMS Pharmaceutical Group Inc. for the supply of 4562070169 Lucentis 0.5 mg/0.05 ml syringes in quantities of 0.05 ml each. The place of performance is Park Ridge, Illinois and the firm fixed price contract runs from August 30, 2023 to September 21, 2023. The Defense Logistics Agency supports Department of Defense health care programs through its medical logistics operations. This delivery order for the eye...
The Defense Logistics Agency awarded a $18,664.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for item number 4561466072, described as Lucentis 0.5 mg/0.05 ml syringes in 0.05 ml doses. The place of performance will be DMS Pharmaceutical's facility located in Park Ridge, Illinois. The period of performance is July 6, 2023 through July 27, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports America's armed forces by...
The Defense Logistics Agency Troop Support Medical awarded a delivery order under an undisclosed contract vehicle to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The firm fixed price order, valued at $8,664.15, is for the delivery of 0.3 mg/0.05 ml syringes of Lucentis to a location in Park Ridge, Illinois. Performance will take place between July 19, 2023 and August 9, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency supports the Department...
The Defense Logistics Agency Troop Support Medical awarded a $3,732.96 delivery order to DMS Pharmaceutical Group Inc. for the supply of 4561367148 Lucentis 0.5 mg/0.05 ml syringes in quantities of 0.05 ml each. The place of performance is Park Ridge, Illinois and the firm fixed price contract runs from June 26, 2023 to July 18, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports Department of Defense health care programs and procurement of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $5,059.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for 0.3 mg/0.05 mL syringes of Lucentis, a branded ophthalmic pharmaceutical product. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB24FB3JY, with a ceiling of up to $4,999,999 that enables DLA to issue delivery orders for a variety of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,544.44, is for the delivery of Lucentis 0.5 mg/0.05 ml syringes to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to...
DMS Pharmaceutical Group Inc. was awarded a firm fixed price delivery order against an unspecified government-wide acquisition contract on April 6, 2023. The $3,021.72 order is for the delivery of 4560647415 units of Lucentis 0.5 mg/0.05 ml syringes to the Defense Logistics Agency in Park Ridge, Illinois. Performance is required by April 27, 2023. No set-aside designation was applied to this order for the pharmaceutical products, which will support the Defense Logistics Agency's medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,088.88 contract will provide LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML medical supplies to support the recurring pharmaceutical needs of military health facilities under the DLA's Medical Supply Chain division. This delivery order is part of a larger $499,999,999 indefinite delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,155.24 contract is for the supply of Lucentis 0.3 mg/0.05 ml syringes to fulfill the recurring pharmaceutical needs of military health facilities. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order (SPE2DX24F5ZZU) valued at $11,583.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide Lucentis 0.5 mg/0.05 ml syringes. This delivery order is part of a larger indefinite delivery contract (SPE2DB), valued up to $499,999,999, that DMS Pharmaceutical Group holds with the DLA to supply a comprehensive range of pharmaceutical products to support the recurring medical...
  • SPE2DB20D9759
    Indefinite Delivery Contract
  • SPE2DB20D9759-SPE2DB23FD5QD
    Delivery Order

The Defense Logistics Agency awarded a $15,108.50 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for the delivery of 0.5 mg/0.05 ml syringes of Lucentis to treat an unspecified medical condition. Performance will take place from September 25 to October 17, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands. This small order for a specialized pharmaceutical product will likely support the medical treatment of active duty military personnel or veterans.

Generated 12/25/23, 9:45 AM